InsightsStrategy & Competition

When film died, Fujifilm started selling anti-ageing cream instead. And it survived.

By Uttam Dinodia2 min readView this post on LinkedIn

Same company, same chemistry, a completely different business.

By the early 2000s, digital was eroding the product behind 60% of Fujifilm's sales. Its chairman, Shigetaka Komori, ordered an eighteen-month audit of every technology the company owned, then asked which of the world's growing needs each could serve.

The answers were strange and profitable.

The chemistry that kept photographs from fading also slowed skin ageing, so in 2007, it launched a skincare brand. Its thin-film coating became the protective layer in LCD screens, where it now holds about seventy percent of the world market.

Its imaging know-how carried it into healthcare and drugs.

In 1980, Derek Abell gave this move a name. A business, he argued, sits on three axes: who you serve, what need you meet, and how you meet it. Most companies fix all three to today's product and call that identity. Fujifilm held the product loosely and rebuilt around the needs its capabilities could serve.

Across the decade, digital gutted film, Fujifilm grew revenue by more than half. The most famous film company in the world, with the same starting product, shrank by almost as much and went bankrupt. PwC reports that 45% of chief executives doubt their company will be viable in 10 years on its current path.

One warning. Redefining a business is not the same as defining it broadly. Say you are in the imaging business, or the happiness business, and you have a slogan rather than a strategy. Critics call that macropia. Fujifilm never reached for a grand abstraction. It named specific capabilities and specific needs. That precision is the whole lesson, because a vague mission sprawls into nothing.

So write down what your organisation is good at, beneath the product you sell.

If that product vanished tomorrow, which of those capabilities would still have a customer? Tell me one in the comments.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.